The application included positive clinical trial results from children who received a booster about six months after their second dose of Pfizer’s vaccine. The shot received emergency use authorization for this age group in October 2021.
At present, boosters are cleared only for people 12 and older.
Pfizer and Moderna are also slated to submit applications for their COVID-19 shots for kids younger than 5 this spring.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
